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Abstract  
A simple and sensitive spectrophotometric determination method for the determination of nitrazepam in bulk, in 
pharmaceutical dosage forms and in biological fluids was developed. The method is based upon reduction of nitro group of 
nitrazepam by zinc and hydrochloric acid followed by diazotization and coupling with orcinol in basic medium to form a stable 
chromophore which absorbs at 470 nm. The method showed a good linearity in the range 0.3 – 3.5µgmL-1. The method is 
free from the interference of common excipients used in pharmaceutical dosage. The method was also used for the 
determination of nitrazepam in pharmaceutical as well as in biological samples. 
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INTRODUCTION 
 
     
Nitrazepam (NTZ), chemically known as 1,3-dihydro-1-nitro-2-
oxo-5-phenyl-2H-1,4- benzodiazepine-2-one (Figure 1) is a hypnotic 
agent belongs to the benzodiazepine class and it has been used in 
the treatment of stress related disorders [1]. The official method for 
its determination is non-aqueous titrimetry reported in British 
Pharmacopoeia [2]. Various other methods based on HPLC [3-5], 
complexometry with cadmium-2-methyl-5- nitrobenzenesuphonate 
[6], polarography [7-8], difference uv- spectrophotometry [9], 
densitometric TLC [10], gas-chromatography [11], micellar 
electrokinetic capillary chromatography [12], and derivative UV- 
spectrophotometry [13] have been reported for the assay of NTZ in 
pharmaceutical formulations. Different manipulation steps are 
involved in some of these methods, which are not simple for the 
routine analysis of pharmaceutical formulations.  
     Spectrophotometric methods are still considered to be a very 
convenient and cost-effective technique, and hence widely used for 
the determination of therapeutics in pure as well as in dosage forms. 
Very few spectrophotometric methods have been reported for 
estimation of NTZ [14-17]. These methods were suffering from one 
or other disadvantages such as lack of selectivity [14-16], the use of 
costly reagent [16] and lower sensitivity [15-16]. Thus, there is a 
need to develop a simple, selective, cost-effective and sensitive 
procedure for the determination of NTZ in pure and in 
pharmaceutical formulations.  
     The present paper describes the development and optimization 
of spectrophotometric methods based on diazo-coupling reaction 
using orcinol as the coupling agents. The developed methods are 
simple, sensitive and accurate for the determination of NTZ in pure 
and in pharmaceutical formulations. 
 
EXPERIMENTAL SECTION  
Apparatus  
 
     A Systronic spectrophotometer was used for absorbance 
measurement. The pH measurements were made with a Systronic 
digital pH- meter (model-335). 
 
Reagents and Standards  
 
     Analytical reagent grade chemicals were used, and double 
distilled water was used throughout the experiment to prepare all 
solutions.  
 
Standard NTZ solution:The pharmaceutical grade NTZ, certified to 
be 99.99% pure were received from Anglo French Drug & Industries 
Ltd., Bangalore India, as a gift sample and were used as received. 
Accurately 10 mg of NTZ was weighed into a 100 mL beaker and 
dissolved NTZ in 5 mL acetone. To this, 5 mL 4 N hydrochloric acid 
and 1 g of zinc dust were added and shaken thoroughly for about 15 
min and then diluted up to the mark with water in a 100 mL calibrated 
flask (100 µg/mL), and filter through Whatman No.41 filter paper. 
Working solutions were prepared as required by dilution. 
 
Orcinol solution: 0.1% orcinol solution was prepared in double 
distilled water. Aqueous solutions of sodium nitrite (Merck) [0.1%], 
sulphamic acid (Qualigens) [3.0% w/v], sodium hydroxide (Merck) [4 
M] and hydrochloric acid (Merck) [1 M and 6 M] were used.  
 
General procedure 
Preparation of calibration curve 
 
     Aliquots of a reduced standard nitrazepam solution (0.4 - 
4.0µgml-1) were placed in a series of 25ml calibrated tube. Then 1 ml 
of 5M HCl and 0.5ml of sodium nitrite solution were added 
successively and allowed to stand for 5 min with occasional shaking 
in an ice bath. Excess  nitrite was removed by addition of 1 ml of 
sulphamic acid then 1 ml of orcinol solution was added. An orange 
yellow solution was obtained after addition of 1 ml of 2M sodium 
hydroxide solution. The solution was made up to the mark with 
distilled water and the absorbance was measured at 465 nm against 
a reagent blank, which gave negligible absorbance at this 
wavelength. 
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     Twenty tablets were weighed accurately and ground into a fine 
powder. Tablets powder equivalent to 10 mg of the NTZ was 
accurately weighed and transferred into a 100 mL beaker. To this 5 
mL 4 N hydrochloric acid and 1 g of zinc dust were added and stirred 
thoroughly for about 30 min. The contents were diluted with 50 mL 
distilled water and filtered using Whatman No. 41 filter paper. The 
filtrate was received into a 100 mL calibrated flask and it was made 
up to the mark with water. Appropriate aliquots of the drug solution 
were taken and the proposed standard procedures were followed for 
analysis of the drug content. 
 
RESULTS AND DISCUSSION 
 
     A new colorimetric method developed for the determination of 
nitrazepam. The method depends upon diazotization of reduced 
Nitrazepam followed by coupling with orcinol in basic medium due to 
which an orange yellow dye formed. The dye has an absorption 
maximum at 465 nm. 
 
Effect of varying reaction conditions 
 
    Effect of reagent concentration: - For reduction of nitrazepam 
molecule use of 10ml of 1M hydrochloric acid and 0.25 gm of zinc 
dust were found optimal. It was found that 0.5ml of sodium nitrite and 
1ml of orcinol were required for maximum colour intensity. Excess 
amount of nitrite caused no effect on absorbance value as the 
addition of sulphamic acid solution removed excess nitrite. There 
was no significant change in the absorbance even if a large excess 
of orcinol was taken. 1 ml of 2M NaOH was required for full colour 
development, excess NaOH decreases the intensity of the colour. 
0.5-5.0 ml of sulphamic acid do not affect the intensity of dye so 1ml 
of sulphamic acid was added for removal of excess nitrite. 
 
Effect of pH time and temperature 
 
     The reduction time 15 min is sufficient to yield maximum 
absorbance. Since for diazotization 2 min or more gave the same 
results after addition of orcinol, it required 5 min for complete colour 
development. 
     Effect of temperature on reduction diazotization and coupling 
was studied. Effect of temperature on reduction rate was studied at 
various temperature ranges. Reduction rate was slow below 35oC 
while it was instantaneous at temperature above 35oC hence 45oC 
was selected for reduction. Diazotization at 0-5oC gives maximum 
colour intensity whereas coupling rate below 10oC was slow hence 
room temperature as selected for coupling. 
     The effect of pH on the reaction was studied maximum intensity 
was found at pH range 10-11 pH hence 1ml of 2M NaOH was used 
in study. 
 
INTERFERENCE 
 
     The effects of common excipients such as talc, glucose, 
dextrose etc. commonly used in pharmaceutical preparations were 
investigated under the optimal conditions. An amount in 1000 fold 
excess of that used in pharmaceutical preparation was added in 0.1 
µgml-1 nitrazepam solution and no effect due to these excipients was 
found under the proposed experimental conditions. 
 
Analytical data 
     Proposed method follows Beer’s law over the concentration 
range of 0.4-4.0µgml-1. The molar absorptivity, sandell’s sensitivity, 
limits of detection, limit of quantification, regression equation, 
correlation coefficients values given in table 1. The precession of the 
method was tested by 6 replicate analysis of solution containing 
2.0µgml-1. The standard deviation and RSD values are given in table 
1. 
 
Application 
Analysis of pharmaceutical preparations: 
 
     The applicability of the proposed method for the assay of 
different pharmaceutical formulations containing nitrazepam 
examined for tablets. For this, 20 tablets crushed and drug 
equivalent to 100 mg was weighed accurately and dissolved in 
methanol and then diluting up to the mark with distilled water. 
Concentration is determined by applying the proposed method. 
     The results were statistically compared with those obtained by 
the official method [4] and by calculating student’s t-test and F-test 
found not to differ significantly. The results summarized in table 2.  
 
Fig 1. Absorption spectra of (a) Blank solution: 0.5mL of 0.1%(w/v) sodium nitrite,  
1 mL of 0.1%(w/v) orcinol, 1ml of 3% (w/v) sulphamic acid and 1mL of 2M NaOH 
solution, (b) Sample solution: Nitrazepam 1.6 µgmL-1 with blank solution in 25 
mL volumetric flask and diluted to volume with distilled water. 
 
Fig 2. Optical absorption spectra with different concentration 
 
Table 1. Analytical parameters for spectrophotometric determination 
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Table 2. Determination of nitrazepam in pharmaceutical preparations 
 
 
 
CONCLUSIONS  
 
     The developed visible spectrophotometric method is simple, 
sensitive, accurate, precise, reproducible and economical and can 
be successfully applied to the routine estimation of nitrazepam in 
bulk and in pharmaceutical dosage forms without the need of 
extraction or heating the reaction mixture. Diazotization was carried 
out at room temperature and cooling to 0-5˚C was not necessary. 
The methods are unaffected by slight variations in the experimental 
conditions such as basicity, reagent concentrations and temperature. 
The value of standard deviation was satisfactorily low and recovery 
was close to 100% which indicates the reproducibility and accuracy 
of the three methods. 
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